The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) met on July 29 to make recommendations for use of vaccine against novel influenza A (H1N1). The committee met to develop recommendations on who should receive vaccine against novel influenza A (H1N1) when it becomes available, and to determine which groups of the population should be prioritized if the vaccine is initially available in extremely limited quantities.

To learn more about these recommendations, go to the news release from the CDC.